arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 0901.3806stat.AP
收藏

长期纵向HIV动力学建模及其在AIDS临床研究中的应用

Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study

Yangxin Huang, Tao Lu

摘要:

一种病毒学标志物,HIV RNA拷贝数或病毒载量,目前用于评估艾滋病临床试验中的抗逆转录病毒(ARV)疗法。该标志物可用于评估抗逆转录病毒治疗的效力,但在长期治疗评估过程中容易受到药物暴露、耐药性等因素的影响。HIV动态研究对理解HIV发病机制和抗逆转录病毒治疗策略有重要贡献。然而,这些研究的模型用于量化短期HIV动力学($<$ 1个月),不适用于描述对ARV治疗的长期病毒学应答,因为难以建立抗病毒应答与多种治疗因素(如长期治疗期间的药物暴露和药物敏感性)的关系。HIV感染者长期接受ARV药物治疗往往导致无法抑制病毒载量。药代动力学(PK)、耐药性和对处方抗病毒药物的不完全遵守是解释病毒死灰复燃的重要因素。为了更好地了解病毒学失败的原因,本文建立了基于机制的非线性微分方程模型,用于描述ARV治疗的长期病毒动力学。这些模型直接将药物浓度、依从性和药物敏感性纳入治疗功效的函数中,因此,将来自艾滋病临床试验的病毒学、PK、药物依从性和耐药性完全整合到分析中。研究了贝叶斯非线性混合效应建模方法与动态微分方程的重标度版本相结合,以估计动态参数并进行推断。此外,基线因素与估计的动态参数的相关性进行了探讨,并提出了一些生物学意义的相关性结果。此外,将病毒学成功患者的估计动态参数与病毒学失败患者的估计动态参数进行比较,并总结了重要的发现。这些结果表明,病毒动力学参数可能在理解HIV发病机制,设计新的治疗策略,为艾滋病患者的长期护理发挥重要作用。

英文摘要:

A virologic marker, the number of HIV RNA copies or viral load, is currently used to evaluate antiretroviral (ARV) therapies in AIDS clinical trials. This marker can be used to assess the ARV potency of therapies, but is easily affected by drug exposures, drug resistance and other factors during the long-term treatment evaluation process. HIV dynamic studies have significantly contributed to the understanding of HIV pathogenesis and ARV treatment strategies. However, the models of these studies are used to quantify short-term HIV dynamics ($<$ 1 month), and are not applicable to describe long-term virological response to ARV treatment due to the difficulty of establishing a relationship of antiviral response with multiple treatment factors such as drug exposure and drug susceptibility during long-term treatment. Long-term therapy with ARV agents in HIV-infected patients often results in failure to suppress the viral load. Pharmacokinetics (PK), drug resistance and imperfect adherence to prescribed antiviral drugs are important factors explaining the resurgence of virus. To better understand the factors responsible for the virological failure, this paper develops the mechanism-based nonlinear differential equation models for characterizing long-term viral dynamics with ARV therapy. The models directly incorporate drug concentration, adherence and drug susceptibility into a function of treatment efficacy and, hence, fully integrate virologic, PK, drug adherence and resistance from an AIDS clinical trial into the analysis. A Bayesian nonlinear mixed-effects modeling approach in conjunction with the rescaled version of dynamic differential equations is investigated to estimate dynamic parameters and make inference. In addition, the correlations of baseline factors with estimated dynamic parameters are explored and some biologically meaningful correlation results are presented. Further, the estimated dynamic parameters in patients with virologic success were compared to those in patients with virologic failure and significantly important findings were summarized. These results suggest that viral dynamic parameters may play an important role in understanding HIV pathogenesis, designing new treatment strategies for long-term care of AIDS patients.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑